Image of hospital equipment and monitor to show NICE coronavirus guidelines on gastrointestinal and liver conditions and acute myocardial injuries

NICE coronavirus guidelines on gastrointestinal and liver conditions and acute myocardial injuries

NICE has published two new rapid coronavirus guidelines on the care of patients with suspected and confirmed COVID-19. They cover the management of disorders of...
Image of a PPE mask to show IQVIA collaborates to launch accelerated COVID-19 infection survey

IQVIA collaborates to launch accelerated COVID-19 infection survey

IQVIA has joined forces with the Office for National Statistics (ONS), Oxford University and UK Biocentre to launch an accelerated COVID-19 infection survey. They will...
Image of coronvirus to show Government launches coronavirus vaccine taskforce as human clinical trials start

Government launches coronavirus vaccine taskforce as human clinical trials start

The UK Government has launched a new coronavirus vaccine taskforce to drive forward, expedite and co-ordinate efforts to research and then produce a coronavirus vaccine....
Image f a man and woman shaking hands to show NICE recommends VITRAKVI ® for children and adults with TRK fusion driven cancer

NICE recommends VITRAKVI® for children and adults with TRK fusion driven cancer

Bayer announced that VITRAKVI® (larotrectinib) was recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of advanced neurotrophic tyrosine...
Image of a bag of blood to show Coronavirus convalescent plasma clinical trial

Coronavirus convalescent plasma wanted for clinical trial

The NHS Blood and Transplant Service is asking for people who’ve recovered from coronavirus (COVID-19) to donate blood plasma, as part of a potential clinical...
Image of a magnifying glass over coronavirus to show Novartis sponsors hydroxychloroquine clinical trial in hospitalised COVID-19 patients

Novartis sponsors hydroxychloroquine clinical trial in hospitalised COVID-19 patients

Novartis has announced that it is to sponsor a large hydroxychloroquine clinical trial in hospitalised COVID-19 patients. Novartis has reached an agreement with the US...
UK pharma company gets expedited MHRA acceptance to start Phase II COVID-19 study

MHRA fast track nod for UK pharma company’s COVID-19 study

4D pharma has received expedited acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to commence a Phase II study of MRx-4DP0004...
Image of a syringe injecting coronavirus to show Roche develops new COVID-19 antibody test

Roche develops new COVID-19 antibody test

Roche has announced the development and upcoming launch of a new COVID-19 antibody test. Its Elecsys® Anti-SARS-CoV-2 serology test will detect antibodies in people...
Image of pharmacy shelves to shw Cegedim launches free pharmacist training during COVID-19

Cegedim launches free pharmacist training during COVID-19

Cegedim launches free digital training to help pharmacists deliver ongoing care throughout COVID-19. Cegedim Rx, part of the innovative healthcare technology and services company, Cegedim,...
Image of a syringe and coronavirus to show Celltrion identify 14 antibodies that neutralise COVID-19 virus

Celltrion identify 14 antibodies that neutralise COVID-19 virus

Celltrion Group has successfully selected the most potent antibody candidates to neutralise COVID-19 virus, SARS-CoV-2. Through a partnership with the Korea Centers for Disease Control...

Latest articles

Reducing the time to market for new COVID-19 vaccines

Reducing time to market for new COVID-19 vaccines

With the target set to offer a COVID-19 vaccine to a further 17.7 million people in the next five priority groups - including all...
NHS gives women Human Papillomavirus Virus (HPV) home testing kits

NHS gives women Human Papillomavirus Virus (HPV) home testing kits

NHS England has announced that more than 31,000 women will be offered kits to carry out HPV self-sampling in the privacy and convenience of...
Tribunal upholds CMA decision on pharma collusion and £1.2m fine

Tribunal upholds CMA decision on pharma collusion and £1.2m fine

The Competition Appeal Tribunal has upheld the Competition and Markets Authority (CMA)’s finding that pharmaceutical firm Lexon broke competition law, dismissing Lexon’s appeal. Last year,...

Popular articles

Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
NHS prescription charge to increase from 1st April

NHS prescription charge to increase from 1 April 2021

The NHS prescription charge will increase to £9.35 per prescription item from 1 April 2021 in England, according to the Pharmaceutical Services Negotiating Committee...
NHS gives women Human Papillomavirus Virus (HPV) home testing kits

NHS gives women Human Papillomavirus Virus (HPV) home testing kits

NHS England has announced that more than 31,000 women will be offered kits to carry out HPV self-sampling in the privacy and convenience of...
Tribunal upholds CMA decision on pharma collusion and £1.2m fine

Tribunal upholds CMA decision on pharma collusion and £1.2m fine

The Competition Appeal Tribunal has upheld the Competition and Markets Authority (CMA)’s finding that pharmaceutical firm Lexon broke competition law, dismissing Lexon’s appeal. Last year,...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription